Maxeon Solar Technologies Initiates TOPCon Patent Infringement Investigation

Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN), a global leader in solar innovation and channels, today announced that it has initiated an investigation of several companies for infringement of Maxeon patents pertaining

Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN), a global leader in solar innovation and channels, today announced that it has initiated an investigation of several companies for infringement of Maxeon patents pertaining to TOPCon (Tunnel Oxide Passivated Contact) solar cell technology in the United States. Several companies have announced plans to import into the United States or manufacture in the United States solar panels that utilize TOPCon solar cells. In response, Maxeon has begun actively monitoring the United States market for the presence of potentially infringing products.

The innovations behind Maxeon IBC, Shingled Hypercell, and TOPCon technologies are protected by a patent portfolio of over 1,600 granted patents and over 360 pending patent applications in the United States of America, China, Australia, Japan, Korea, Germany, France, and the Netherlands. 

“Maxeon is a leader in solar cell technology, having developed, commercialized and practiced tunnel oxide passivated contact technology on our solar cells for over 15 years,” said Lindsey Wiedmann, Maxeon’s Chief Legal & Sustainability Officer. “We will rigorously defend our intellectual property rights should Maxeon determine its TOPCon patents have been infringed. Innovation depends on a patent system that rewards and protects the investments necessary to create such innovation. As a global, industry-leading solar company, Maxeon strongly supports fair competition in the marketplace and appreciates the importance of intellectual property rights of all participants in the industry. This also means that we intend to formidably defend our intellectual property rights when they are violated. Earlier this year we filed lawsuits against Tongwei with respect to our Shingled Hypercell technology and against Aiko with respect to our IBC technology. We plan to continue to meticulously defend our intellectual property around IBC, Shingled Hypercell, and TOPCon technologies.”

Total
0
Shares
Related Posts
Read More

Weed Giant Canopy Announces Upsized $35M Private Placement

Canadian cannabis producer Canopy Growth has raised $35m from a private placement of tranched units with "certain institutional investors". Each unit comprised one common share and one class A or class B common share purchase warrant, with series A exercisable for five years immediately following the placement's close, and series B after six months. The proceeds will give the Ontario-based company more financial clout, allowing it to pay down debt and giving it some marketing cash. In November, Canopy cut its debt by C$364m, bringing its total debt reduction to C$1bn ($798m) since the start of the fiscal year. The company is now hoping to cut costs further, targeting a C$300m reduction by the end of the current fiscal year.

CGC